Roche: 2% growth in sales at constant exchange rates in Q1
Excluding Covid-19-related products, sales rose by 7%', says the Swiss healthcare group, adding that 'going forward, there will be no further significant impact from the decline in Covid-19-related sales'.
Roche is therefore confident of achieving sales growth 'in the mid-single digits' this year (at constant exchange rates), and confirms its outlook for 2024.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction